Stay updated on Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page shows Revision: v3.5.3, updating the prior revision tag from v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-30T19:10:40.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T11:18:09.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Updated eligibility criteria now allow concurrent hormonal or anti-HER2 therapy if brain metastases progress; MRI criteria were revised to require at least 2 untreated measurable brain metastases (≥3 mm) within two weeks before treatment, and prior subtotal resection is permitted if residual disease <4 cm.
    Difference
    0.5%
    Check dated 2026-04-02T05:42:46.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Site revision history updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T20:21:11.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T18:20:48.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed on the page. The funding-status notice corresponding to Revision: v3.4.1 has been removed.
    Difference
    0.4%
    Check dated 2026-02-11T05:20:21.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial page.